Thai Optical Group Valuation
Is TOG-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TOG-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TOG-R (THB11.3) is trading above our estimate of fair value (THB9.89)
Significantly Below Fair Value: TOG-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TOG-R?
Other financial metrics that can be useful for relative valuation.
What is TOG-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿5.36b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.2x |
Enterprise Value/EBITDA | 10.1x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does TOG-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 50.9x | ||
STGT Sri Trang Gloves (Thailand) | 153.9x | n/a | ฿23.5b |
NAM Namwiwat Medical Corporation | 16.9x | 31.3% | ฿3.4b |
EKH Ekachai Medical Care | 18.4x | 4.5% | ฿5.5b |
NTV Nonthavej Hospital | 14.6x | n/a | ฿5.7b |
TOG-R Thai Optical Group | 12.6x | n/a | ฿5.4b |
Price-To-Earnings vs Peers: TOG-R is good value based on its Price-To-Earnings Ratio (12.6x) compared to the peer average (50.9x).
Price to Earnings Ratio vs Industry
How does TOG-R's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Earnings vs Industry: TOG-R is good value based on its Price-To-Earnings Ratio (12.6x) compared to the Asian Medical Equipment industry average (24.5x).
Price to Earnings Ratio vs Fair Ratio
What is TOG-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 12.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate TOG-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.